HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reply to Eugenio Ventimiglia, Andrea Salonia, and Francesco Montorsi's Letter to the Editor re: Moritz von Büren, Severin Rodler, Isabell Wiesenhütter, et al. Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction. Eur Urol Focus 2022;8:794-802.

AuthorsMoritz von Büren, Christian Wülfing, Sabine D Brookman-May, Christian Gratzke, Johannes von Büren
JournalEuropean urology focus (Eur Urol Focus) Vol. 9 Issue 5 Pg. 846-847 (09 2023) ISSN: 2405-4569 [Electronic] Netherlands
PMID37061364 (Publication Type: Letter, Comment)
Chemical References
  • Sildenafil Citrate
  • Tadalafil
  • severin protein, Dictyostelium
Topics
  • Male
  • Humans
  • Erectile Dysfunction
  • Sildenafil Citrate
  • Tadalafil
  • Patient Preference

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: